Pular para o conteúdo principal
Ranking Invest

TEVA - Teva Pharmaceutical Industries Limited

Segmento: HealthcareTeva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.

Análise Ranking Invest

Valor de Mercado
$ 46.62 Bi
IVR
0.12Índice proprietário de comparação relativa: 0,12.
IVR2
-0.04Leitura proprietária complementar: -4%.
MLL
-0.04Leitura proprietária complementar: -4%.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia proprietária baseada em dados financeiros públicos; fórmulas e valores intermediários são confidenciais.

Dados da Empresa

Patrimônio Líquido

$ 7.75 Bi

Dívida Líquida

$ 5.34 Bi

L4T

$ 707.00 Mi

MM4T

9.27%

Indicadores Básicos

ROE

9.12%

Índices de Previsibilidade

Receita Líquida

B0.04

Lucro

F3.35

Margem

G27.19

Índices de Tendência

Receita Líquida

C7.41

Lucro

B4.96

Margem

B5.56

Índices de Endividamento

DIV/PAT

0.69

DIV/L4T

7.56

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.